Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
Fuente:
Wiley Open Access
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artículo Open Access |
| Veröffentlicht: |
Wiley
2024
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1867002206498062336 |
|---|---|
| author | Lvzhuo Zhang Shifeng He Lian Liu Jiangrong Huang |
| author_facet | Lvzhuo Zhang Shifeng He Lian Liu Jiangrong Huang Lvzhuo Zhang Shifeng He Lian Liu Jiangrong Huang |
| collection | Wiley Open Access |
| contents | Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications Lvzhuo Zhang Shifeng He Lian Liu Jiangrong Huang Phytotherapy Research AbstractType 2 diabetes mellitus (T2DM), a metabolic disease with persistent hyperglycemia primarily caused by insulin resistance (IR), has become one of the most serious health challenges of the 21st century, with considerable economic and societal implications worldwide. Considering the inevitable side effects of conventional antidiabetic drugs, natural ingredients exhibit promising therapeutic efficacy and can serve as safer and more cost‐effective alternatives for the management of T2DM. Saponins are a structurally diverse class of amphiphilic compounds widely distributed in many popular herbal medicinal plants, some animals, and marine organisms. There are many saponin monomers, such as ginsenoside compound K, ginsenoside Rb1, ginsenoside Rg1, astragaloside IV, glycyrrhizin, and diosgenin, showing great efficacy in the treatment of T2DM and its complications in vivo and in vitro. However, although the mechanisms of action of saponin monomers at the animal and cell levels have been gradually elucidated, there is a lack of clinical data, which hinders the development of saponin‐based antidiabetic drugs. Herein, the main factors/pathways associated with T2DM and the comprehensive underlying mechanisms and potential applications of these saponin monomers in the management of T2DM and its complications are reviewed and discussed, aiming to provide fundamental data for future high‐quality clinical studies and trials. 10.1002/ptr.8229 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/ptr.8229 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_ptr_8229 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications Lvzhuo Zhang Shifeng He Lian Liu Jiangrong Huang Phytotherapy Research Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications Lvzhuo Zhang Shifeng He Lian Liu Jiangrong Huang Phytotherapy Research AbstractType 2 diabetes mellitus (T2DM), a metabolic disease with persistent hyperglycemia primarily caused by insulin resistance (IR), has become one of the most serious health challenges of the 21st century, with considerable economic and societal implications worldwide. Considering the inevitable side effects of conventional antidiabetic drugs, natural ingredients exhibit promising therapeutic efficacy and can serve as safer and more cost‐effective alternatives for the management of T2DM. Saponins are a structurally diverse class of amphiphilic compounds widely distributed in many popular herbal medicinal plants, some animals, and marine organisms. There are many saponin monomers, such as ginsenoside compound K, ginsenoside Rb1, ginsenoside Rg1, astragaloside IV, glycyrrhizin, and diosgenin, showing great efficacy in the treatment of T2DM and its complications in vivo and in vitro. However, although the mechanisms of action of saponin monomers at the animal and cell levels have been gradually elucidated, there is a lack of clinical data, which hinders the development of saponin‐based antidiabetic drugs. Herein, the main factors/pathways associated with T2DM and the comprehensive underlying mechanisms and potential applications of these saponin monomers in the management of T2DM and its complications are reviewed and discussed, aiming to provide fundamental data for future high‐quality clinical studies and trials. 10.1002/ptr.8229 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications |
| topic | Phytotherapy Research |
| url | https://onlinelibrary.wiley.com/doi/10.1002/ptr.8229 |